John Haines
Analyst · Wedbush Securities. Your line is open
Yes, David, what we've said on the fixed cost as you saw – when we talked about fixed cost in the corporation, we're talking about the combination of those fixed cost that were in our cost to goods sold, fixed manufacturing cost plus SG&A. That unit entirely is down about 14% when you look at it in the third quarter, quarter-over-quarter. That improvement is the combination of some of the restructuring actions that we've taken, including discrete fixed cost actions. So some of our business units have the most significant revenue challenge have taken actions relative to their fixed cost, selling and marketing and other costs. And then, of course, a portion of it is FX as well. So, we estimate around 50% or thereabout, so that 14% reduction is related to FX. As we look forward for the full year and then beyond, we're hopeful to be in a fixed cost range of combination again of those two categories, somewhere in the $302 million to $305 million annual run rate is kind of how we see ourselves ending this year. So, now, there's going to be some giveback in 2016, right. There's a portion of that that's variable compensation that we'll have to add back, you’ll start to lapse some of those FX that will have some impact. But when you compare that to the 2014 total of about $324 million, we're significantly below, and we feel like we'll be positioned significantly below that. So, the key question for us is, what will – what are the right things to add back? Perhaps, for example, on R&D, we cut back a little bit on some of the R&D efforts that we had intended this year simply because of the year we were having, some of that will come back, and that's – but we still – the point is we're still – we feel like in a much better run rate position as we end 2015 and enter into 2016 on that total fixed cost base.